Trevi Therapeutics, Inc.

NasdaqGM:TRVI Stock Report

Market Cap: US$223.7m

Trevi Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TRVI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders917,3801.19%
Hedge Funds9,426,93112.3%
General Public17,774,19823.1%
VC/PE Firms18,751,46624.4%
Institutions29,995,73639%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.4%.


Top Shareholders

Top 25 shareholders own 72.17% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
New Enterprise Associates, Inc.
11,370,376US$33.1m0%1.4%
9.6%
Frazier Life Sciences Management, LP
7,381,090US$21.5m0%0.82%
6.54%
Rubric Capital Management LP
5,026,931US$14.6m0%0.2%
5.72%
Viking Global Investors LP
4,400,000US$12.8m0%0.04%
4.45%
VR Adviser, LLC
3,422,656US$10.0m0%0.45%
4.24%
The Vanguard Group, Inc.
3,262,381US$9.5m33.8%no data
4.19%
BlackRock, Inc.
3,221,752US$9.4m2.76%no data
3.58%
Logos Global Management, L.P.
2,750,000US$8.0m-1.79%0.9%
3.34%
Opaleye Management Inc.
2,567,990US$7.5m-2.91%1.09%
2.1%
Vivo Capital, LLC
1,612,903US$4.7m0%0.37%
2%
BioImpact Capital LLC
1,538,517US$4.5m1.88%0.68%
1.73%
MAI Capital Management, LLC
1,327,285US$3.9m0.67%0.03%
1.72%
Ally Bridge Group
1,322,800US$3.8m-10.3%1.31%
1.64%
Geode Capital Management, LLC
1,264,166US$3.7m10.2%no data
1.24%
State Street Global Advisors, Inc.
952,912US$2.8m5.9%no data
0.98%
Rosalind Advisors, Inc.
750,000US$2.2m-46.1%1.32%
0.79%
Woodline Partners LP
606,227US$1.8m0%0.01%
0.63%
Silverarc Capital Management, LLC
482,575US$1.4m-42.8%0.31%
0.56%
Northern Trust Global Investments
433,642US$1.3m35.1%no data
0.55%
Landscape Capital Management, LLC
424,725US$1.2m-29.9%0.11%
0.46%
David Meeker
352,489US$1.0m0%no data
0.38%
Acuta Capital Partners, LLC
290,500US$845.4k11.7%0.68%
0.33%
Checkpoint Capital, LLC, Asset Management Arm
250,000US$727.5k-50%0.34%
0.31%
Tejara Capital Limited., Asset Management Arm
241,613US$703.1k-40.5%0.31%
0.29%
Thomas Sciascia
220,315US$641.1k2.74%no data